HC Wainwright Increases Earnings Estimates for Adlai Nortye

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) – Equities researchers at HC Wainwright upped their FY2026 earnings per share estimates for Adlai Nortye in a note issued to investors on Monday, April 20th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per share of ($0.23) for the year, up from their prior forecast of ($0.24). HC Wainwright has a “Buy” rating and a $20.00 price objective on the stock. The consensus estimate for Adlai Nortye’s current full-year earnings is ($0.20) per share.

ANL has been the topic of several other research reports. Leerink Partners started coverage on Adlai Nortye in a report on Friday, March 20th. They issued an “outperform” rating and a $23.00 price objective on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, January 21st. Finally, Wall Street Zen upgraded Adlai Nortye to a “hold” rating in a report on Saturday, March 7th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $21.50.

Adlai Nortye Stock Performance

NASDAQ ANL opened at $16.13 on Wednesday. The stock’s 50-day simple moving average is $9.68 and its two-hundred day simple moving average is $4.98. Adlai Nortye has a twelve month low of $0.88 and a twelve month high of $17.25.

Institutional Investors Weigh In On Adlai Nortye

An institutional investor recently raised its position in Adlai Nortye stock. SmartHarvest Portfolios LLC boosted its holdings in shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) by 8.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,367 shares of the company’s stock after purchasing an additional 1,279 shares during the period. SmartHarvest Portfolios LLC’s holdings in Adlai Nortye were worth $113,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 35.21% of the company’s stock.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.